found that β4 integrins activate the human epidermal growth factor receptor 2 (HER2) expressed on the breast cancer cells to activate the expression of VEGF, thereby mediating tumour cell anchorage to the basal lamina of the brain microvasculature. Here, ERBB2 is linked to breast carcinoma.